Regulatory and Quality Requirements for Combination Products
-
Training ID: ELT248
-
Customization: Available
-
Certificate: Included
-
TalkFDA AfterCare™: Included
-
Training Mode: Onsite / Virtual / Streaming
-
Skill Level: Beginner / Intermediate / Advanced
-
Duration: Half-Day / Full-Day / Multi-Day
-
Course Format: Workshop / Masterclass / Bootcamp
Why This Training Matters
Combination products sit at the fault line between drug, device, and biologic regulations. That reality creates friction inside organizations. Quality teams debate which cGMP standard applies. Regulatory submissions stall over unclear classification logic. Design controls drift away from manufacturing controls. Postmarket surveillance signals fall between functions.
The operational risk is not theoretical. FDA observations routinely cite weak quality management system integration, fragmented risk management, and incomplete validation strategies when multiple regulatory frameworks collide. Misalignment between development, manufacturing, and regulatory affairs often leads to rework, delayed approvals, and inspection pressure under FDA 21 CFR Part 4.
Teams struggle most where accountability is blurred-especially at interfaces between design controls, process validation, and complaint handling. Without a shared interpretation of expectations, even mature organizations make avoidable mistakes that escalate quickly during inspections or partner audits.
TalkFDA Elite Training Labs helps teams align interpretation, execution, and documentation through realistic scenarios grounded in how regulators actually assess combination product operations.
Common Challenges Companies Face
-
Unclear ownership between drug and device quality systems
-
Incomplete alignment between design controls and cGMPs
-
Gaps in integrated risk management documentation
-
Validation approaches that ignore constituent interactions
-
Inspection responses fragmented across departments
Context Behind This Topic
Combination products bring together constituent parts that would otherwise be regulated separately, such as a drug delivered through a device or a biologic packaged with a delivery system. Global regulators expect these products to meet all applicable requirements without duplication or gaps.
In the U.S., oversight is coordinated across FDA centers, with clear expectations defined under 21 CFR Part 4. Similar principles appear across EU MDR, ISO standards, and ICH guidance, all emphasizing integrated quality systems, lifecycle risk management, and clear ownership of controls. Regulatory and Quality Requirements for Combination Products apply across development, validation, manufacturing, distribution, and Post market activities.
Teams often struggle because legacy systems were built around single-mode products. Documentation structures, SOPs, and validation approaches may not scale cleanly when design controls intersect with drug GMPs. The result is confusion during audits and inconsistent execution on the shop floor.
Understanding the regulatory intent-not just the clauses-allows organizations to build practical, inspection-ready systems that hold up across regions and product lifecycles.
Who This Training Is Designed For
Quality Assurance (QA), Quality Control (QC), Regulatory Affairs (RA), Combination Product Program Management, Medical Device Quality Engineering, Drug Product Manufacturing Leadership, Validation Engineering, Computerized System Validation (CSV), Design Control Management, Risk Management and CAPA Owners, Clinical Operations Leadership, Postmarket Surveillance and Vigilance Teams, Supply Chain Quality Management, Technical Documentation and Labeling, Manufacturing Operations Management, Product Development and Lifecycle Management, Executive Quality and Compliance Leadership overseeing Regulatory and Quality Requirements for Combination Products
Core Learning Themes
-
Interpreting FDA combination product expectations
-
Risk management across constituent parts
-
Postmarket surveillance and feedback loops
-
Applying 21 CFR Part 4 correctly
-
Validation strategies for integrated products
-
Clear roles and accountability models
-
Integrating design controls with GMPs
-
Inspection-ready documentation structures
-
Building a unified quality management system
-
Minor adjustments to these themes may be made following the Clarity & Context Call to align the workshop with your team’s specific needs.
The TalkFDA Elite Training Framework
How We Build Your Training
1. Clarity & Context Call
2. Smart Structuring & Fine-Tuning
3. Focused Delivery
4. TalkFDA AfterCare™ Reinforcement
Customization & Delivery Options
Designed for deeper alignment, richer discussion, and team-wide clarity inside your facility.
Ideal for distributed teams, tight timelines, or phased learning — structured for engagement without compromise.
Local, regional, or international SMEs depending on subject matter, language, and urgency.
We tune the workshop to your context while retaining a strong, proven training architecture.
What Your Team Receives
-
TalkFDA Certificate of Completion for all participants, ready for your training files and audit binders.
-
AfterCare™ reinforcement window (14–21 days post-training)
-
Workshop materials or summaries where applicable
-
Guided insights tailored to your workflows and compliance expectations
FAQs
Do you offer onsite and virtual formats?
Yes. Onsite is recommended for full-team alignment, while virtual options suit distributed teams.
Can the workshop be customized?
Yes — the emphasis and examples are adapted to your facility and team needs.
What is the workshop duration?
Most onsite sessions are full-day or two-day programs. Virtual sessions may use 3–4 hour modules.
What is included in the TalkFDA AfterCare™?
TalkFDA AfterCare™ includes A 14–21 day window for clarification-level questions as your team begins applying the training.
Will participants receive certificates?
Yes, every participant receives a TalkFDA Certificate of Completion.
How much does this training cost?
We’ll share a clear proposal once we understand your needs
Ready to Strengthen Your Team? Let’s Build Your Training Plan.
Your team deserves the clarity.
Your organization deserves the confidence.
Alan Forest
Training Advisor
Aishwarya Meenakshi
Training Advisor
Tina Thompson
Training Advisor
BUILT BY EXPERTS. BACKED BY EXPERIENCE. DESIGNED FOR LIFESCIENCES.
Learn Together. Grow Together. Win Together.
The go-to platform and expert-led community helping life sciences teams stay compliant, confident, and ahead.
Credit Card required to activate Trial.
You won’t be charged unless you choose to continue after the trial period.
TalkFDA Affiliate Program — Terms & Conditions
1. Joining the Program
- By registering, you agree to these terms.
- Approval of applications is at TalkFDA’s sole discretion.
2. Affiliate Commissions
- Commission Rate: 20% of net sales (after refunds/discounts).
- Commission applies to initial purchase and recurring renewals.
- Payments are made monthly via [payment method] after a 30-day refund period.
3. Tracking & Attribution
- Tracking is done via unique Affiliate IDs.
- Last-click attribution is used (the most recent affiliate link gets credit).
- TalkFDA is not responsible for untracked sales caused by ad blockers, browser issues, or customer error.
4. Prohibited Practices
Affiliates must not:
- Use spam, fake accounts, bots, or misleading claims.
- Misrepresent TalkFDA’s services or guarantees.
- Bid on TalkFDA’s name, brand, or trademarks in paid search ads without prior permission.
- Self-refer (you can’t earn commission from your own purchases).
5. Promotion Guidelines
- Affiliates may promote via websites, blogs, social media, email lists (opt-in only).
- Promotion must be professional and respectful to TalkFDA’s reputation.
- Certain content (adult, hate speech, political, illegal) is strictly prohibited.
6. Termination
- TalkFDA reserves the right to suspend or terminate an affiliate account for any breach of these terms, or if the affiliate’s activity harms TalkFDA’s reputation.
- Any unpaid commissions may be forfeited if termination is due to violation of terms.
7. Liability
- Affiliates act as independent promoters and are not employees of TalkFDA.
- TalkFDA is not liable for indirect, special, or consequential damages related to the program.
8. Changes to the Program
- TalkFDA may update commission rates, terms, or program rules at any time.
- Affiliates will be notified of changes by email or via the Affiliate Dashboard.
9. Governing Law
- These terms are governed by the laws of Canada.
Welcome to TalkFDA Learning
Thank you for your purchase!
Some emails from TalkFDA may be filtered by company email systems.
- Please check the Inbox inside My Space (top right corner).
- Add @talkfda.com to your safe sender list.
Access & Support Information
-
Please check your Spam / Junk folder if you don’t receive emails shortly after purchase.
-
In some organizations, emails may be quarantined by IT security systems — you may need to contact your IT team.
-
We recommend adding @talkfda.com to your Safe Senders / Allow List.
Your TalkFDA Webinar Experience
1. Confirmation
3. Join the Live Training
4. Watch Again Anytime
Everything related to your webinar: access, materials, playback, and certification — lives in one place.

